Ventilator-associated pneumonia (VAP) is one of the most frequent ICU-acquired infections.
Reported incidences vary widely from 5 to 40% depending on the setting and diagnostic …

In recent years, the worldwide spread of the so-called high-risk clones of multidrug-resistant
or extensively drug-resistant (MDR/XDR) Pseudomonas aeruginosa has become a public …

Introduction Pseudomonas aeruginosa nosocomial pneumonia (Pa-NP) is associated with
considerable morbidity, prolonged hospitalization, increased costs, and mortality. Methods …

Respiratory infections are a major cause of global mortality and morbidity. In recent years,
an increased incidence of multidrug‐resistant (MDR) Gram‐negative bacteria (GNB) has …

Objective Pseudomonas aeruginosa often presents multi-drug resistance (MDR) in intensive
care unit (ICU)-acquired pneumonia (ICUAP), possibly resulting in inappropriate empiric …

Community-acquired pneumonia (CAP) is a common cause for admission to the hospital
and contributes significantly to patient morbidity and healthcare cost. We present a review of …

Due to the increasing prevalence of HAP/VAP caused by MDR Gram-negative pathogens,
management should be guided by the local ecology and the patient's risk factors for MDR …

Pseudomonas aeruginosa is the most common gram-negative pathogen causing
pneumonia in immunocompromised patients. Acute lung injury induced by bacterial …

Introduction Nosocomial pneumonia develops after≥ 48 h of hospitalisation and is
classified as ventilator-associated pneumonia (VAP) and hospital-acquired pneumonia …

Ventilator-associated pneumonia (VAP) is an iatrogenic pulmonary infection that develops in
tracheally intubated patients on mechanical ventilation for at least 48 hours. VAP is the …